Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CPIX Cumberland Pharmaceutical Inc

1,56

0,05 (3,31%)

21 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Cumberland Pharmaceutical (NASDAQ:CPIX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Cumberland Pharmaceutical Charts.

Cumberland Pharmaceutical (NASDAQ:CPIX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Cumberland Pharmaceutical Charts.

News Cumberland Pharmaceutical Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Dienstag 7 Mai 2024 (2 Wochen vor) • PR Newswire (US)

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
Dienstag 30 April 2024 (3 Wochen vor) • PR Newswire (US)

NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
Dienstag 2 April 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Dienstag 5 März 2024 (3 Monate vor) • PR Newswire (US)

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
Dienstag 27 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 9 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 28 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 28 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 28 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere Cumberland Pharmaceutical Inc News-Artikel

Horizons BetaPro COMEX S...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen